Dr. John Thomas Slevin

Department of Neurology

University of Kentucky College of Medicine, USA

Email: jslevin@uky.edu

Qualifications

1999 M.B.A., University of Kentucky, Gatton College of Business and Economics

1975 M.D., West Virginia University, Medicine

1971 Ph.D., Johns Hopkins University, Biochemistry

1970 B.A., Johns Hopkins University, Biology

Publications (selected)

1. Pankratz, N., Wilk, J.B. et al. and the Gene-PD Study Group. Genomewide association study for susceptibility genes contributing to familial Parkinson’s disease. Human Genetics 124 (6): 593-605, 2009.
2. Slevin, J.R. and SLEVIN, J.T. Neurological Examination of Veterans with Traumatic Brain Injury. Vocational Evaluation & Work Adjustment Association Journal 38(1): 18-26, 2011.
3. Espay, A.J., Dwivedi, A.K., Payne, M., Gaines, L, Vaughan, J.E., Maddux, B.N., SLEVIN, J.T., Gartner, M., Sahay, A., Revilla, F.J., Duker, A.P., and Shukla, R. Methylphenidate for gait impairment in Parkinson’s disease: a randomized clinical trial. Neurology 76: 1256-62, 2011.
4. Zaheer, F and SLEVIN, J.T. Trichloroethylene and Parkinson’s disease. Neurology Clinics 29(3): 657-65, 2011.
5. Blonder, L.X. and SLEVIN, J.T. Emotional Dysfunction in Parkinson’s Disease. Behavioral Neurology 24(3): 201-217, 2011.
6. Latourelle, J.C. et al. and the Gene-PD Study Group. Genomewide linkage study of modifiers of LRRK2-related Parkinson’s disease. Mov Disord 26 (11): 2039-44, 2011.
7. Matveeva, E.A., Davis, V.A., Whiteheart, S.W., Vanaman, T.C., Gerhardt, G.A. and SLEVIN, J.T. Kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes correlates with enhanced glutamate release. Epilepsia 53(1): 157-167, 2012.
8. Matveeva, E.A., Price, D.A., Whiteheart, S.W., Vanaman, T.C., Gerhardt, G.A. and SLEVIN, J.T. Reduction of VAMP2 Expression leads to a Kindling-Resistant Phenotype in a Murine Model of Epilepsy. Neuroscience 202: 77-86, 2012. doi:10.1016/j.neuroscience.2011.11.055 .
9. Richard, I.H., McDermott, M.P., McDonald, W., Kurlan, R., Lyness, J., Como, P.G., Pearson, N, Factor, S., Juncos, J., Ramos, C.S., Brodsky, M., Manning, C., Marsh, L., Shulman, L., Fernandez, H., Black, K., Panisset, M., Chadwick, C., Jiang, W., Singer, C., Horn, C., Pfeiffer, R., Rottenberg, D., SLEVIN, J., Elmer, L., Press, D., Hyson, H.C. and the SAD-PD Study Group*. Treatment of Depression in Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial of Paroxetine and Venlafaxine Extended Release. Neurology 78: 1229-1236, 2012.
10. Xu, G. et al. and the Gene-PD Study Group. R.H. Type-1 Protein Phosphatase Inhibitor 4 (I-4) on Xp11.4-11.3 is Associated with Familial and Idiopathic Parkinson’s disease: The Gene PD Study. American Journal of Human Genetics, submitted.
11. Nagle, M.W. et al. and the Gene-PD Study Group. Polymorphisms and Expression in SIRT3 are associated with Parkinson disease: the GenePD Study. Neurology, submitted.
12. SLEVIN, J.T. and Ryan, M.H. Chapter 8: Headache. In: Clinical Adult Neurology, 3rd Edition (J.Corey-Bloom, Ed.), Demos Medical Publishing, New York, pp. 123-147, 2009.
13. Whiteheart, S.W., Matveeva, E.A., Vanaman, T.C. and SLEVIN, J.T. Presynaptic neurotransmission: Alterations in exocytotic/secretory machinery in kindling. In: Encyclopedia of Basic Epilepsy Research, Vol. 2 (P.A. Schwartzkroin, Ed.), Elsevier/Academic Press, Oxford, UK, pp. 892-897, 2009.
14. Vanaman, T.C., Whiteheart, S.W., Matveeva, E.A., SLEVIN, J.T. Proteomic approaches to the analysis of protein alterations at the synapse in kindling. In: Encyclopedia of Basic Epilepsy Research, Vol. 2 (P.A. Schwartzkroin, Ed.), Elsevier/Academic Press, Oxford, UK, pp. 1176-1181, 2009.
15. Gash, D.M., Gerhardt, G.A. and SLEVIN. J.T. GDNF and Neurturin: Neuroprotection and Neurorestoration in Parkinson’s Disease. In: Encyclopedia of Movement Disorders, Vol. 1 (K. Kompoliti, L. Verhagen, Eds.), Elsevier/Academic Press, Oxford, UK, pp. 534-537, 2010.

Profile Details

Null